XML 89 R69.htm IDEA: XBRL DOCUMENT v3.19.2
SEGMENT INFORMATION (Summary of Reportable Segments) (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
segment
Jun. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Financial information regarding the Company's reportable segments          
Number of reportable segments | segment     3    
Net sales $ 742,661 $ 710,608 $ 1,487,121 $ 1,413,958  
Acquisition related costs (1,281) (2,563) (1,281) (2,563)  
Total Restructuring Initiatives 1,737 18,214 11,267 24,150  
Depreciation and amortization 47,867 40,101 95,356 81,276  
Interest expense (8,756) (7,964) (17,970) (16,019)  
Interest income 1,033 2,521 2,781 4,769  
Income before Income Taxes 102,101 74,898 192,100 156,115  
Capital Expenditures     124,774 91,753  
Total Assets 3,588,716   3,588,716   $ 3,377,735
Employee severance          
Financial information regarding the Company's reportable segments          
Total Restructuring Initiatives     3,209    
Business Transformation          
Financial information regarding the Company's reportable segments          
Total Restructuring Initiatives 1,700 18,200 11,300 24,200  
Beauty + Home          
Financial information regarding the Company's reportable segments          
Net sales 342,080 368,536 709,739 746,709  
Adjusted EBITDA 48,745 45,846 101,936 98,981  
Total Restructuring Initiatives 1,259 14,631 9,528 19,647  
Pharma          
Financial information regarding the Company's reportable segments          
Net sales 281,939 241,209 554,640 471,336  
Adjusted EBITDA 101,650 86,353 199,007 166,193  
Total Restructuring Initiatives (113) 1,224 213 1,588  
Food + Beverage          
Financial information regarding the Company's reportable segments          
Net sales 118,642 100,863 222,742 195,913  
Adjusted EBITDA 20,944 18,063 37,635 30,802  
Total Restructuring Initiatives 112 1,354 622 1,669  
Corporate & Other          
Financial information regarding the Company's reportable segments          
Adjusted EBITDA (10,630) (9,043) (23,385) (20,622)  
Total Restructuring Initiatives 479 1,005 904 1,246  
Operating segment          
Financial information regarding the Company's reportable segments          
Net sales 752,925 716,863 1,505,649 1,426,103  
Operating segment | Beauty + Home          
Financial information regarding the Company's reportable segments          
Net sales 349,253 374,161 722,756 757,624  
Operating segment | Pharma          
Financial information regarding the Company's reportable segments          
Net sales 284,577 241,282 559,071 471,414  
Operating segment | Food + Beverage          
Financial information regarding the Company's reportable segments          
Net sales 119,095 101,420 223,822 197,065  
Intersegment          
Financial information regarding the Company's reportable segments          
Net sales 10,264 6,255 18,528 12,145  
Intersegment | Beauty + Home          
Financial information regarding the Company's reportable segments          
Net sales 7,173 5,625 13,017 10,915  
Intersegment | Pharma          
Financial information regarding the Company's reportable segments          
Net sales 2,638 73 4,431 78  
Intersegment | Food + Beverage          
Financial information regarding the Company's reportable segments          
Net sales $ 453 $ 557 $ 1,080 $ 1,152